INTERRELATION OF VITAMIN E ISOFORMS AND ATHEROGENESIS MARKERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (literature review and own results)

Authors

  • Gorshunska M. Y. Kharkiv Postgraduate Medical Academy, Kharkiv

DOI:

https://doi.org/10.21856/j-PEP.2015.1.11

Keywords:

alpha tocopherol, gamma tocopherol, type 2 diabetes mellitus, atherogenesis

Abstract

The review is dedicated to the biological role of two the most commonly encountered vitamin E forms, i. e. alpha tocopherol and gamma tocopherol. Literature data provide evidence of vitamin E capability to have influence on gene activity as well as processes associated with cardiovascular complications progression. In our study gamma tocopherol was determined as minor form of vitamin E in Ukrainian (Kharkiv) population. However increase of gamma tocopherol in examined patients with type 2 diabetes mellitus on the background of identified proinflammatory and proatherogenic characteristics of gamma tocopherol makes the case for dietary adjustment in such patients’ cohort. Relative deficit of alpha tocopherol revealed in examined patients gives evidence of perspective of complex antioxidative therapy administration for cardiovascular complications progression prevention/suppression.

References

Evans HM, Bishop KS. Science 1922; 56:650-651.

Mustacich DJ, Bruno RS, Traber MG. Vitam Horm 2007; 76:1-21.

Herrera E, Barbas C. J Physiol Biochem 2001; 57:43-56.

Traber MG. Annu Rev Nutr 2007; 27:347-362.

Manolescu B, Atanasiu V, Cercasov C, et al. J Med Life 2008; 1:376-382.

Niki E, Traber MG. Ann Nutr Metab 2012; 61:207-212.

Muller L, Theile K, Bohm V. Mol Nutr Food Res 2010; 54:731-742.

Poltorak VV, Krasova NS, Gorshunskaja MJu. Probl Endokryn Patologii’ 2012; 3:91-103.

Gorshunskaja MJu. Probl Endokryn Patologii’ 2012; 3:113-124.

Galli F, Azzi A. Biofactors 2010; 36:33-42.

Boscoboinik D, Szewczyk A, Azzi A. Arch Biochem Biophys 1991; 286:264-269.

Azzi A, Gysin R, Kempna P, et al. Ann NY Acad Sci 2004; 1031:86-95.

Das Evcimen N, King GL. Pharmacol Res 2007; 55(6):498-510.

Geraldes P, King GL. Circ Res 2010; 106:1319-1331.

Giacco F, Brownlee M. Cir Res 2010; 107:1058-1070.

Azzi A. Eur J Nutr 2004; 43(1):I18-I25.

Rimbach G, Moehring J, Huebbe P, Lodge JK. Molecules 2010; 15:1746-1761.

Mocchegiani E, Costarelli L, Giacconi R, et al. Ageing Res Rev 2014; 15:81-101.

Morante M, Sandoval J, Gomez-Cabrera MC, et al. Free Radic Res 2005; 39(10):1127-1138.

Rota C, Rimbach G, Minihane AM, et al. Nutr Neurosci 2005; 8:21-29.

Barella L, Rota C, Stocklin E, Rimbach G. Ann NY Acad Sci 2004; 1031:334-336.

Boyd SD. Lab Invest 2008; 88:569-578.

Lewis BP, Burge CB, Bartel DP. Cell 2005; 120:15-20.

Esau C, Davis S, Murray SF, et al. Cell Metab 2006; 3:87-98.

Tili E, Michaille JJ, Cimino A, et al. J Immunol 2007; 179:5082-5089.

Gaedicke S, Zhang X, Schmelzer C, et al. FEBS Lett 2008; 582:354-546.

Hamar P. Nucleic Acid Ther 2012; 22(5):289-294.

Kadamkode V, Banerjee G. Microrna 2014; 3(2):86-97.

Wagner KH, Kamal-Eldin A, Elmadfa I. Ann Nutr Metab 2004; 48(3):169-188.

Reiter E, Jiang Q, Christen S. Mol Aspects Med 2007; 28(5-6):668-691.

Patel A, Liebner F, Mereiter K, et al. J Org Chem 2007; 72:6504-6512.

Cook-Mills JM, McCary CA. Endocr Metab Immune Disord Drug Targets 2010; 10(4):348-366.

Berdnikovs S, Abdala-Valencia H, McCary C, et al. J Immunol 2009; 182:4395-4405.

Morrish NJ, Wang SL, Stevens LK, et al. Diabetologia 2001; 44(2):S14-S21.

Devaraj S, Jialal I. Free Radic Biol Med 2005; 38(9):1212-1220.

Jiang Q. Free Radic Biol Med 2014; 72:76-90.

Wood AD, Strachan AA, Thies F, et al. Br J Nutr 2014; 112(8):1341-1352.

Montero D, Walther G, Stehouwer CD, et al. Obes Rev 2014; 15(2):107-116.

Rafraf M, Bazyun B, Sarabchian M A, et al. Health Promot Perspect 2012; 2(1):72-79.

Salonen RM, Nyyssonen K, Kaikkonen J, et al. Circulation 2003; 107(7):947-953.

Kritharides L, Stocker R. Atherosclerosis 2002; 164(2):211-219.

Heart Protection Study Collaborative Group. Lancet 2002; 360(9326):23-33.

Ward NC, Wu JH, Clarke MW, et al. J Hypertens 2007; 25:227-234.

Saremi A, Arora R. Am J Ther 2010; 17:e56-e65.

Miller 3rd ER, Pastor-Barriuso R, Dalal D, et al. Ann Intern Med 2005; 142:37-46.

Lodge JK. J Plant 2005; 162:79-96.

Devaraj S, Jialal I. Nutr Rev 2005; 63(8):290-293.

Lemaire-Ewing S, Desrumaux C, Neel D, Lagrost L. Mol Nutr Food Res 2010; 54(5):631-640.

Werba JP, Cavalca V, Vaglia F, et al. Atherosclerosis 2007; 193(1):70-74.

Downloads

Published

2021-06-23

How to Cite

Gorshunska, M. Y. (2021). INTERRELATION OF VITAMIN E ISOFORMS AND ATHEROGENESIS MARKERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (literature review and own results) . Problems of Endocrine Pathology, 51(1), 80-89. https://doi.org/10.21856/j-PEP.2015.1.11

Most read articles by the same author(s)